Your browser doesn't support javascript.
loading
The efficacy of schema therapy for personality disorders: a systematic review and meta-analysis.
Zhang, Kaiyuan; Hu, Xinyang; Ma, Lijun; Xie, Qihang; Wang, Zhipeng; Fan, Chuan; Li, Xiaoming.
Afiliação
  • Zhang K; Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Hu X; Department of Clinical Medical, First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China.
  • Ma L; Research Centre for Translational Medicine, the Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
  • Xie Q; Department of Medical Psychology, School of Mental Health and Psychological Science, Anhui Medical University, Hefei, Anhui, China.
  • Wang Z; Department of Clinical Medical, First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China.
  • Fan C; Department of Clinical Medical, First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China.
  • Li X; Department of Psychiatry, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Nord J Psychiatry ; 77(7): 641-650, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37402124
ABSTRACT

OBJECTIVE:

Personality disorders (PDs) are prevalent and associated with functional impairment and psychological disability. Studies suggest that schema therapy (ST) may be an effective treatment for PDs. This review aimed to evaluate the efficacy of ST in treating PDs.

METHOD:

We conducted a comprehensive literature search using PubMed, Embase, Web of Science, CENTRAL, PsycInfo, and Ovid Medline. We identified eight randomized controlled trials (587 participants) and seven single-group trials (163 participants).

RESULTS:

Meta-analyses revealed that ST had a moderate effect size (g = 0.359) compared to control conditions in reducing symptoms of PDs. Subgroup analysis indicated that the effect of ST on different types of PDs varied slightly, and that group ST (g = 0.859) was more effective than individual ST (g = 0.163) in treating PDs. Secondary outcome analysis revealed a moderate effect size (g = 0.256) for ST compared to control conditions in improving quality of life, and ST was found to reduce early maladaptive schema (g = 0.590). Single-group trials analysis showed that ST had a positive effect on PDs (OR = 0.241).

CONCLUSION:

ST appears to be an effective treatment for PDs, as it reduces symptoms and improves quality of life. This review provides support for the use of ST in the treatment of PDs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicoterapia de Grupo / Terapia do Esquema Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicoterapia de Grupo / Terapia do Esquema Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article